SCS in Itch
- Conditions
- ot applicable
- Registration Number
- NL-OMON23833
- Lead Sponsor
- Erasmus University Medical Centre
- Brief Summary
one
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
Good effect of SCS or DRGS; the area innervated by the SCS or DRGS must extend to a healthy, pain free area of skin; participants must not have objections against switching off his or her SCS or DRGS for up to one hour; age >= 18 years; no ongoing itch perception.
Exclusion Criteria
Generalized skin disorder; systemic disease associated with pruritus; complex regional pain syndrome; allergy or hypersensitivity; contra-indications for histamine administration; use of opioids; use of drugs that might potentially prevent the development of a flare.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS for itch.
- Secondary Outcome Measures
Name Time Method Size of flare, character and constancy of itch.